Securian Asset Management Inc. Sells 471 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Securian Asset Management Inc. trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 19,144 shares of the medical equipment provider’s stock after selling 471 shares during the period. Securian Asset Management Inc.’s holdings in Intuitive Surgical were worth $9,992,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $449,000. Seilern Investment Management Ltd acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $82,517,000. Sycomore Asset Management grew its holdings in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Exome Asset Management LLC grew its holdings in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. grew its holdings in shares of Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 2.3 %

NASDAQ:ISRG opened at $493.72 on Wednesday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market cap of $175.85 billion, a price-to-earnings ratio of 77.02, a PEG ratio of 5.85 and a beta of 1.43. The stock has a 50-day moving average price of $569.91 and a two-hundred day moving average price of $531.84.

Analyst Ratings Changes

ISRG has been the topic of several recent research reports. Leerink Partners lifted their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Barclays raised their target price on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Royal Bank of Canada raised their target price on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Truist Financial raised their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Finally, JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 489 shares of the company’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $533.18, for a total transaction of $260,725.02. Following the completion of the transaction, the senior vice president now directly owns 2,091 shares of the company’s stock, valued at $1,114,879.38. This represents a 18.95 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Jamie Samath sold 269 shares of the company’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,309 shares of company stock valued at $7,611,004. Company insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.